SNDY

Solos Endoscopy (PK) Stock Price

0.0037
0.00 (0.0%)
0.0037
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Solos Endoscopy Inc (PK) SNDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0037 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.0037
Bid Price Ask Price Spread News
0.0027 0.068 0.0653 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0037 USD

Solos Endoscopy (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 18.47k 4.99M 273.42k $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
423.00 $ - 0.00% - -

more financials information »

Solos Endoscopy (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNDY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.00320.0090.00270.0044969632,1600.000515.63%
6 Months0.00410.0090.00260.0043906197,160-0.0004-9.76%
1 Year0.00250.0090.00160.0040486152,7590.001248.0%
3 Years0.00490.0090.00120.0038972149,951-0.0012-24.49%
5 Years0.0470.150.00120.0139351297,404-0.0433-92.13%

Solos Endoscopy (PK) Description

CYduct Diagnostics, Inc., headquartered in Westport, Connecticut, develops, produces, and markets medical products for the assessment, identification, diagnosis and ultimately treatment of early-stage breast disease. CYduct will provide personalized risk assessment tools and help identify precancerous and cancerous lesions within the mammary ducts. The CYduct technology platforms will be single-use, proprietary, high-margin, high-volume suite of breast care products which assess, screen, detect, monitor and treat identifiable changes that distinguish variations in breast health. CYduct is committed to providing both women and clinicians with noninvasive and minimally invasive technology that will continue to accelerate the intraductal evolution and improvement in the ability to: 1) assess breast health risk, 2) monitor breast health, 3) identify the need for increased personalized risk surveillance and 4) provide the tools to monitor, diagnose/treat breast disease through visual examination (Breast Endoscopy) within the ductal system of the breast.


Your Recent History
USOTC
SNDY
Solos Endo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.